These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6674472)

  • 41. Influence of the acute intraperitoneal administration of tetrazepam on blood glucose level and serum lipids in normoglycemic and normolipidemic rats.
    Horák J; Cuparencu B; Horák A
    Acta Physiol Hung; 1997-1998; 85(4):347-51. PubMed ID: 10431605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of boletus aereous on blood lipids and antioxidant action in hyperlipidemia in rats].
    Wang YX; Yang GZ; Di Y; Su YG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):355. PubMed ID: 15498262
    [No Abstract]   [Full Text] [Related]  

  • 43. Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives.
    Reddy KA; Lohray BB; Bhushan V; Reddy AS; Rao Mamidi NV; Reddy PP; Saibaba V; Reddy NJ; Suryaprakash A; Misra P; Vikramadithyan RK; Rajagopalan R
    J Med Chem; 1999 Aug; 42(17):3265-78. PubMed ID: 10464013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of novel triterpenoid (lupeol) derivatives and their in vivo antihyperglycemic and antidyslipidemic activity.
    Papi Reddy K; Singh AB; Puri A; Srivastava AK; Narender T
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4463-6. PubMed ID: 19515563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihyperlipidemic effect of Garlip, a polyherbal formulation in streptozotocin induced diabetic rats.
    Sharmila Banu G; Kumar G; Murugesan AG
    Food Chem Toxicol; 2009 Sep; 47(9):2361-5. PubMed ID: 19555732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Regulation effect of curcumin on blood lipids and antioxidation in hyperlipidemia rats].
    Wang S; Chen B; Sun C
    Wei Sheng Yan Jiu; 2000 Jul; 29(4):240-2. PubMed ID: 12520931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats.
    Figarola JL; Scott S; Loera S; Xi B; Synold T; Rahbar S
    Ann N Y Acad Sci; 2005 Jun; 1043():767-76. PubMed ID: 16037304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Chemistry of phenoxyacetic acid esters of oxyalkyltheophyllines and 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methyl-propionate] (etofylline clofibrate), a novel antilipaemic agent (author's transl)].
    Metz G; Specker M
    Arzneimittelforschung; 1980; 30(11b):2014-9. PubMed ID: 7194051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 4-(Phenylsulfonamidomethyl)benzamides as potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1 with efficacy in diabetic ob/ob mice.
    Zhang X; Zhou Z; Yang H; Chen J; Feng Y; Du L; Leng Y; Shen J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4455-8. PubMed ID: 19564108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.
    Henke BR; Blanchard SG; Brackeen MF; Brown KK; Cobb JE; Collins JL; Harrington WW; Hashim MA; Hull-Ryde EA; Kaldor I; Kliewer SA; Lake DH; Leesnitzer LM; Lehmann JM; Lenhard JM; Orband-Miller LA; Miller JF; Mook RA; Noble SA; Oliver W; Parks DJ; Plunket KD; Szewczyk JR; Willson TM
    J Med Chem; 1998 Dec; 41(25):5020-36. PubMed ID: 9836620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Sulfonamides. 10. Sulfonamide derivatives of 1-thiocarbamyl-3-methylpyrazolone-(5) and 1-thiocarbamyl-3,5-dimethylpyrazole].
    Wreciono U; Krzysztofik B; Nieweglowska W
    Pharmazie; 1976 Apr; 31(4):216-7. PubMed ID: 935222
    [No Abstract]   [Full Text] [Related]  

  • 52. Acute effects of zopiclone on blood glucose level and serum lipids in hyperlipidemic rats.
    Cuparencu B; Horák J; Horák A; Tiglea M
    Acta Physiol Hung; 2000; 87(2):193-9. PubMed ID: 11205968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sulfonamides acting on the central nervous system, VI.
    Monzani A; Gamberini G; Braghiroli D; Di Bella M; Raffa L; Sandrini M
    Arch Pharm (Weinheim); 1985 Apr; 318(4):299-304. PubMed ID: 4004513
    [No Abstract]   [Full Text] [Related]  

  • 54. Preparation and skin-photosensitizing activity of xanthotoxin sulphonamides.
    Loutfy MA; Abu-Shady HA
    Pharmazie; 1977 Apr; 32(4):240. PubMed ID: 896915
    [No Abstract]   [Full Text] [Related]  

  • 55. Amino acids and peptides. V. Synthesis of amino acid derivatives containing a sulfonamide bond.
    Maeda M; Okada Y; Sogabe M; Kawasaki K
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2137-41. PubMed ID: 4053237
    [No Abstract]   [Full Text] [Related]  

  • 56. [New drug specialities, registered in Austria].
    Wien Klin Wochenschr; 1973 Nov; 85(48):798-9. PubMed ID: 4753091
    [No Abstract]   [Full Text] [Related]  

  • 57. New compounds: synthesis of 3,4,5-trimethoxybenzenesulfonamides.
    Piffer G; Monguzzi R
    J Pharm Sci; 1973 Aug; 62(8):1392-4. PubMed ID: 4725200
    [No Abstract]   [Full Text] [Related]  

  • 58. [Sulfonamides acting on the central nervous system. IV. 2-Acylaminobenzenesulfon-N-acylamides].
    Raffa L; Di Bella M; Di Bella L; Conti G
    Farmaco Sci; 1966 Mar; 21(3):196-208. PubMed ID: 5934255
    [No Abstract]   [Full Text] [Related]  

  • 59. Biological actions of the natural coumarins. I. Changes of lipids and glucose levels in rat plasma after intraperitoneal administration of various linear-type furanocoumarins.
    Yasuda M; Baba K; Kozawa M
    Chem Pharm Bull (Tokyo); 1984 Nov; 32(11):4650-2. PubMed ID: 6532562
    [No Abstract]   [Full Text] [Related]  

  • 60. Purine sulfonamides.
    Beaman AG; Tautz W; Duschinsky R; Grunberg E
    J Med Chem; 1966 May; 9(3):373-8. PubMed ID: 5960910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.